NCT04913519View on ClinicalTrials.gov

A Phase 1 Study of TDM-105795 Topical Solution in Male Subjects With Androgenetic Alopecia (AGA)

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 27, 2021

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Alopecia, Androgenetic
Interventions
DRUG

TDM-105795

TDM-105795 topical solution

DRUG

Placebo

Placebo for TDM-105795 topical solution

Trial Locations (2)

77845

J&S Studies, Inc., College Station

92123

TCR Medical Corporation, San Diego

All Listed Sponsors
collaborator

Therapeutics, Inc.

INDUSTRY

lead

Technoderma Medicines Inc.

INDUSTRY